OrganoTherapeutics is a spin-off project from the University of Luxembourg. OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen for novel compounds which can be therapeutic for different patient sub-groups.
We use a set of computational AI tools to perform deep phenotyping of our models to better detect cellular defects and their rescue following compound treatments.
TechnologiesAI Companies (Drug Discovery)
No pipelines published yet
No services posted yet